Pharmaceuticals, Biotechnology and Life Sciences
Pharmacy-based plan expands hormone coverage, menopause-trained Care Guides and analytics to deliver a clinically proven approach to pharmacy benefits BETHESDA,…
Multi-year collaboration enables advanced diagnostic imaging and center of excellence in imaging sciences department across PET/CT, SPECT/CT, CT, MRI, and…
Served more than 35 years at Vetter, 23 years in the management Remains at the company in an advisory capacity…
Biomarker-activated cancer drug-candidate LP-184 demonstrates encouraging efficacy signals in DNA damage repair deficient tumors with an acceptable safety and tolerability…
Novel CD28 x Nectin-4 bispecific designed to overcome limitations of ADCs through durable and well-tolerated tumor-directed immune co-stimulation Milestone marks…
New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity…
Financing co-led by new investors, Ascenta Capital and Bessemer Venture Partners Additional new investors included YK Bioventures, Regeneron Ventures, Invus,…
SAN ANTONIO, Texas–(BUSINESS WIRE)–#ACS—bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other…
– Mike Bonney and Carolyn Bertozzi to Depart; Company Appoints Stuart Arbuckle as New Independent Director – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam…
Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical…